Results 221 to 230 of about 712,965 (355)

SYHA1813, A VEGFR and CSF1R Inhibitor, in Patients With Recurrent High‐Grade Gliomas: A Multicenter, Open‐Label Phase I Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Recurrent high‐grade gliomas have a poor prognosis and limited therapeutic options. This study aimed to evaluate the safety and efficacy of SYHA1813, a dual inhibitor of VEGFR and CSF1R, in patients with recurrent high‐grade gliomas.
Zhuang Kang   +16 more
wiley   +1 more source

Importancia de la revisión por pares en la construcción del conocimiento: una mirada desde la Revista Española de Nutrición Humana y Dietética

open access: yesRevista Española de Nutrición Humana y Dietética
Claudia Andrea Troncoso Pantoja   +15 more
doaj   +1 more source

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

open access: yesBlood, 2017
H. Döhner   +21 more
semanticscholar   +1 more source

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We report the 12‐month follow‐up outcomes from a Phase 2 clinical trial (NCT04146051) evaluating Descartes‐08, a BCMA‐directed RNA chimeric antigen receptor T‐cell (rCAR‐T) therapy for refractory generalized myasthenia gravis (MG).
Nizar Chahin   +10 more
wiley   +1 more source

Exercise prescriptions for patients on hemodialysis in Brazil: a scoping review. [PDF]

open access: yesJ Bras Nefrol
Ribeiro HS   +6 more
europepmc   +1 more source

The 2017 international classification of the Ehlers–Danlos syndromes

open access: yesAmerican Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 2017
F. Malfait   +44 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy